COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01504334
Recruitment Status : Unknown
Verified February 2012 by Zuojun Xu, Beijing Kawin Technology Share-Holding Co., Ltd..
Recruitment status was:  Recruiting
First Posted : January 5, 2012
Last Update Posted : February 7, 2012
Information provided by (Responsible Party):
Zuojun Xu, Beijing Kawin Technology Share-Holding Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 2012
Estimated Study Completion Date : March 2013